Möchten Sie immer auf dem neuesten Stand bleiben?

SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic...

Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 15, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global hip reconstruction...

Continue to advance hypoimmune technology in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Enrolling patients in the GLEAM trial for...

New Delhi, July 11, 2024 (GLOBE NEWSWIRE) -- The global hemostats market is projected to hit the valuation of US$ 4,568.90 million by 2032 up from US$ 2,744.28 million in 2023 at a CAGR of 8.7%...

NEWARK, Del, July 10, 2024 (GLOBE NEWSWIRE) -- The global viscosupplementation Market is projected to reach USD 2,167.3 million in 2024. The viscosupplementation demand is expected to witness a...

Rockville, MD, July 10, 2024 (GLOBE NEWSWIRE) -- Revenue from the global orthopedic implants market size is anticipated to reach US$ 44.94 billion in 2024, as stated in the recently updated industry...

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...

New York, United States , June 21, 2024 (GLOBE NEWSWIRE) -- The Global Endoprosthesis Market Size is to Grow from USD 23.58 Billion in 2023 to USD 67.58 Billion by 2033, at a CAGR of 11.10% during...

New York, United States , June 14, 2024 (GLOBE NEWSWIRE) -- The Global Viscosupplementation Market Size is to Grow from USD 4.20 Billion in 2023 to USD 9.15 Billion by 2033, at a Compound Annual...

Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Ongoing ARDENT trial for SC291 continues in B-cell...